Genomic sequence analysis of hMSH2 and hMLHL in high and low risk groups

J. C. Ling*, Y. Wang, J. Lingoerke, S. Farrington, M. Dunlop, D. Robbins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Hereditary nonpolyposis colorectal cancer (HNPCC) is an aiHosomal dominant inherited disease characterized by predisposition to colorectal carcinoma (CRC) at an early age. Two (hMSH2. hMLHl I of the lour genes identified and shown to be altered in the germline of HNPCC patients account for the majority of mutations. To establish criteria for clinical laboratory testing, we compared genomic DNA sequence analysis of these two genes in control donors (n=20) and patients (n=59) with early onset CRC (<40 years). Eighteen (30%) different germline mutations were identified in the high-risk group. A splicing mutation was identified in two control donors (10%) and six (30%) were categorized as "indeterminate" as there is no evidence linking the mutations to disease. We also analyzed four HNPCC families for mutations found in their respective proband and identified all eleven (100%) affected family members and three who are at risk. Analysis of individuals at high risk for CRC minimizes ambiguities between mutations and non-disease polymorphisms.

Original languageEnglish
JournalFASEB Journal
Issue number9
Publication statusPublished - 1 Dec 1997


Dive into the research topics of 'Genomic sequence analysis of hMSH2 and hMLHL in high and low risk groups'. Together they form a unique fingerprint.

Cite this